 
- 积分
- 416
- 威望
- 416
- 包包
- 1859
|
HIGHLIGHTS OF PRESCRIBING
+ q X4 s' F. Y3 o6 R; y* ~INFORMATION
1 }9 H% V% H. E5 |& o( kThese highlights do not include all of the
7 L3 V& C- ^! \4 f; Y0 d1 I, [information needed to use PROVENGE®
g$ N$ l, j" G7 m8 ]9 O5 P, o
: a c0 F4 ]: _( k- J: \3 h! ~& r(sipuleucel - T) safely and effectively. See f ull 7 b) M( ~, |# `; F
prescribing information for PROVENGE. * {# j) @$ U( A; t. ~6 K$ S6 B
PROVENGE® (sipuleucel - T)
! m- }% e* D! ]; x% g0 J; xSuspension for Intravenous Infusion
! B' i w6 y# a6 sInitial U.S. Approval: 2010 % w8 N- t5 q: D* F2 ~
- - - - - - - INDICATIONS AND USAGE - - - - - - |
-
总评分: 威望 + 2
包包 + 10
查看全部评分
|